Abemaciclib
CDK 4/6 inhibitor
Verzenio
62 trials
Indicated for 1 condition
CDK 4/6 inhibitor
Verzenio
62 trials
Indicated for 1 condition
CYP17A1 inhibitor
Zytiga
89 trials
Indicated for 1 condition
Enzyme replacement
Replagal
17 trials
Indicated for 1 condition
Anti-CD52 antibody
Lemtrada
58 trials
Indicated for 2 conditions
Immunosupressant
Litak, Mavenclad, Leustatin
62 trials
Indicated for 2 conditions
MEK inhibitor
Cotellic
32 trials
Indicated for 1 condition
Anti-CD38 antibody
Darzalex
113 trials
Indicated for 1 condition
Estrogen Receptor Antagonists
test
test
10 trials
Indicated for 1 condition
CFTR modulator
Trikafta, Kaftrio
12 trials
Indicated for 1 condition
Bispecific monoclonal antibody
Hemlibra
3 trials
Indicated for 1 condition
S1PR modulators
Gilenya
69 trials
Indicated for 1 condition
Selective estrogen receptor degrader
Faslodex
25 trials
Indicated for 1 condition
Immunosupressant
Glatiramer acetate
Glatiramer acetate
0 trials
Indicated for 1 condition
Enzyme replacement
Cerezyme
15 trials
Indicated for 1 condition
Anti-HER2 TKI
Tykerb, Tyverb
67 trials
Indicated for 1 condition
CDK 4/6 inhibitor
0 trials
Indicated for 1 condition
CDK 4/6 inhibitor
Ibrance
82 trials
Indicated for 1 condition
CDK 4/6 inhibitor
Kisqali
54 trials
Indicated for 1 condition
Glutamate modulator
Rilutek
85 trials
Indicated for 1 condition
Anti-HER2 antibody-drug conjugate
Kadcyla
40 trials
Indicated for 1 condition